![Evaluation of the renal parenchymal retention of iodinated contrast agent during follow-up computed tomography performed one day after undergoing contrast-enhanced computed tomography - European Journal of Radiology Evaluation of the renal parenchymal retention of iodinated contrast agent during follow-up computed tomography performed one day after undergoing contrast-enhanced computed tomography - European Journal of Radiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f347198e-c858-4d6b-873c-4ab063b8353f/gr1.jpg)
Evaluation of the renal parenchymal retention of iodinated contrast agent during follow-up computed tomography performed one day after undergoing contrast-enhanced computed tomography - European Journal of Radiology
![Contrast enhanced X-ray computed tomography imaging of amyloid plaques in Alzheimer disease rat model on lab based micro CT system | Scientific Reports Contrast enhanced X-ray computed tomography imaging of amyloid plaques in Alzheimer disease rat model on lab based micro CT system | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-021-84579-x/MediaObjects/41598_2021_84579_Fig1_HTML.png)
Contrast enhanced X-ray computed tomography imaging of amyloid plaques in Alzheimer disease rat model on lab based micro CT system | Scientific Reports
![Groups Publish Statements on CT Contrast Use in Patients with Kidney Disease | Imaging Technology News Groups Publish Statements on CT Contrast Use in Patients with Kidney Disease | Imaging Technology News](http://www.itnonline.com/sites/default/files/Iodine_Contrast_2-attached_to_contrast_injector_CT_computed_tomography-Aquilion_one_CDH_Staff_photo_DF.jpg)
Groups Publish Statements on CT Contrast Use in Patients with Kidney Disease | Imaging Technology News
![PDF] To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. | Semantic Scholar PDF] To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/4cb33b8a483f4a4749311917c88c8bfa8170143c/2-Figure1-1.png)
PDF] To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. | Semantic Scholar
Computed Tomography Imaging of Solid Tumors Using a Liposomal-Iodine Contrast Agent in Companion Dogs with Naturally Occurring Cancer | PLOS ONE
![Nanoparticles as computed tomography contrast agents: current status and future perspectives | Nanomedicine Nanoparticles as computed tomography contrast agents: current status and future perspectives | Nanomedicine](https://www.futuremedicine.com/cms/10.2217/nnm.11.190/asset/images/medium/figure2.gif)
Nanoparticles as computed tomography contrast agents: current status and future perspectives | Nanomedicine
![Contrast Agent Pooling (C.A.P.) sign and imminent cardiac arrest: a retrospective study | BMC Emergency Medicine | Full Text Contrast Agent Pooling (C.A.P.) sign and imminent cardiac arrest: a retrospective study | BMC Emergency Medicine | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12873-022-00634-4/MediaObjects/12873_2022_634_Fig1_HTML.png)